Universitätsklinikum Regensburg

Hospital


Location: Regensburg, Germany (DE) DE

ISNI: 0000000091947179

ROR: https://ror.org/01226dv09

Show on Map:


close-button

Types of publications

Journal article
Book chapter / Article in edited volumes
Authored book
Translation
Thesis
Edited Volume
Conference contribution
Other publication type
Unpublished / Preprint

Publication year

From
To

Abstract

Journal

In-vitro blockade of the CD4 receptor co-signal in antigen-specific T-cell stimulation cultures induces the outgrowth of potent CD4 independent T-cell effectors (2018) Vatter S, Schmid M, Gebhard C, Mirbeth C, Klobuch S, Rehli M, Herr W, Thomas S Journal article The peripheral and intratumoral immune cell landscape in cancer patients: A proxy for tumor biology and a tool for outcome prediction (2018) Schnell A, Schmidl C, Herr W, Siska PJ Journal article, Review article Force-Feedback Assisted Bone Drilling Simulation Based on CT Data (2018) Maier J, Huber M, Katzky U, Perret J, Wittenberg T, Palm C Conference contribution, Original article Multicenter pilot study of radiochemotherapy as first-line treatment for adults with medulloblastoma (NOA-07) (2018) Beier D, Proescholdt M, Reinert C, Pietsch T, Jones DTW, Pfister SM, Hattingen E, et al. Journal article Indoxyl 3-sulfate inhibits maturation and activation of human monocyte-derived dendritic cells (2018) Ghimire S, Matos C, Caioni M, Weber D, Peter K, Holler E, Kreutz M, Renner K Journal article Drug safety in and by emergency departments: What risks can occur in the indication, application and dosage? Arzneimittelsicherheit in und durch Notaufnahmen (2018) Ittner KP, Koeniger R, Dormann H, Zimmermann M Journal article Sympathomimetics in emergency medicine: A review Sympathomimetika in der Notfallmedizin: ein überblick (2018) Ittner KP, Dormann H Journal article Pre- and post-diagnosis physical activity, television viewing, and mortality among hematologic cancer survivors (2018) Schmid D, Behrens G, Arem H, Hart C, Herr W, Jochem C, Matthews CE, Leitzmann MF Journal article Biomodulatory treatment with azacitidine, all-trans retinoic acid and pioglitazone induces differentiation of primary AML blasts into neutrophil like cells capable of ROS production and phagocytosis (2018) Klobuch S, Steinberg T, Bruni E, Mirbeth C, Heilmeier B, Ghibelli L, Herr W, et al. Journal article Targeting immune modulatory pathways in cancer (2018) Beckhove P Journal article